Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
Crossref DOI link: https://doi.org/10.1186/s13104-017-3086-7
Published Online: 2017-12-21
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tawaratsumida, Hiroki
Setoguchi, Takao
Arishima, Yoshiya
Ohtsubo, Hideo
Akimoto, Masaki
Ishidou, Yasuhiro
Nagano, Satoshi
Taketomi, Eiji
Sunahara, Nobuhiko
Komiya, Setsuro